Al Nahdi Medical Company SJSC banner

Prices of SAU stocks are not being updated. The latest Al Nahdi Medical Company SJSC price on Alpha Spread is from Aug 7, 2024. Financials, forecasts and intrinsic value keep updating.

Wall St Price Targets

Price Forecast
Based on 12 analysts

-9% Downside
from ﷼129.2 today

Al Nahdi Medical Company SJSC (4164)’s 12-month stock price forecast through August 2025 has a consensus target of ﷼117.3, implying 9% downside. The forecast is based on price targets from 12 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Al Nahdi Medical Company SJSC yet.

Al Nahdi Medical Company SJSC Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Al Nahdi Medical Company SJSC's stock price target?
Price Target
117.3 SAR

According to Wall Street analysts, the average 1-year price target for Al Nahdi Medical Company SJSC is 117.3 SAR with a low forecast of 101 SAR and a high forecast of 149.1 SAR.

What is the Revenue forecast for Al Nahdi Medical Company SJSC?
Projected CAGR
8%

Over the last 7 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 4 years is 8%.

What is the Gross Profit forecast for Al Nahdi Medical Company SJSC?
Projected CAGR
8%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 4 years is 8%.

What is the Operating Income forecast for Al Nahdi Medical Company SJSC?
Projected CAGR
8%

Over the last 7 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 4 years is 8%.

What is the Pre-Tax Income forecast for Al Nahdi Medical Company SJSC?
Projected CAGR
5%

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 5%.

What is the Net Income forecast for Al Nahdi Medical Company SJSC?
Projected CAGR
7%

Over the last 7 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 4 years is 7%.

Back to Top